Latest Publications
Ovarian Cancer Surgical Consideration Is Markedly Improved by the Neural Network Powered-MIA3G Multivariate Index Assay
Highlights how the neural network-powered MIA3G multivariate index assay could significantly enhance surgical decision-making for ovarian cancer.
Neural Network-Derived Multivariate Index Assay Demonstrates Effective Clinical Performance in Longitudinal Monitoring of Ovarian Cancer Risk
Details the clinical performance of a neural network-derived multivariate index assay in the ongoing monitoring of ovarian cancer risk.
Improving the Diagnostic Accuracy of an Ovarian Cancer Triage Test Using a Joint miRNA-Protein Model
Study on enhancing the diagnostic accuracy of ovarian cancer triage tests through a combined miRNA-protein model.
A reflex testing protocol using two multivariate index assays improves the risk assessment for ovarian cancer in patients with an adnexal mass
Reflexing samples with intermediate OVA1 scores significantly decreases the false-positive rate, thereby reducing unnecessary specialty referrals.
Analytical Validation of a Deep Neural Network Algorithm for the Detection of Ovarian Cancer
The paper validates the use of a deep neural network algorithm, OvaWatch(R), in detecting ovarian cancer risk.
Clinical Performance of a Multivariate Index Assay in Detecting Early-Stage Ovarian Cancer in Filipino Women
Study demonstrates the high clinical performance of a multivariate index assay in detecting early-stage ovarian cancer in Filipino women, highlighting its potential as a valuable risk assessment tool for this population.
Salvaging Detection of Early-Stage Ovarian Malignancies When CA-125 Is Not Informative
The paper discusses methods to improve early-stage ovarian malignancy detection when CA-125 is not informative, using a multivariate index assay.
Low-Risk Multivariate Index Assay Scores, Physician Referral and Surgical Choices in Women with Adnexal Masses
Use of Ova1 drove referrals of malignant adnexal masses to Gyn/Oncs which is associated with improved cancer outcomes and overall survival. This practice is safe and may be cost-saving, with patient satisfaction implications.
Ethnic Disparity in Clinical Performance Between Multivariate Index Assay and CA-125 in Detection of Ovarian Malignancy
Examination of the ethnic disparities in the performance of multivariate index assay compared to CA125 in detecting ovarian malignancies.
Multivariate Index Assay Is Superior to CA-125 and HE4 Testing in Detection of Ovarian Malignancy in African-American Women
This study shows the superiority of the multivariate index assay over CA125 and HE4 tests in detecting ovarian malignancies in African-American women.
Economic Impact of Increased Utilization of Multivariate Assay Testing to Guide the Treatment of Ovarian Cancer: Implications for Payers
The results of the budget impact model support the use of OVA1 instead of CA125 by indicating that modest cost-savings can be achieved, while reaping the clinical benefits of improved diagnostic accuracy, early disease detection, and reductions in multiple, and possibly unnecessary, referrals to gynecologic oncologists
The Clinical Utility of an Elevated-Risk Multivariate Index Assay Score in Ovarian Cancer Patients
The publication investigates the clinical utility of elevated-risk scores from a multivariate index assay in the management of ovarian cancer patients.
Validation of a Second-Generation Multivariate Index Assay for Malignancy Risk of Adnexal Masses
This paper presents the validation of a second-generation multivariate index assay for assessing malignancy risk in adnexal masses.
Cost Effectiveness of a Multivariate Index Assay Compared to Modified ACOG Criteria and CA-125 in the Triage of Women with Adnexal Masses
Analysis of the cost-effectiveness of using a multivariate index assay versus modified ACOG criteria and CA125 for triaging women with adnexal masses.
The Effect of Ovarian Imaging on the Clinical Interpretation of a Multivariate Index Assay
Imaging, OVA1 score, and menopausal status independently affected ovarian risk in women with adnexal mass planned for surgery. The results helped define how ultrasound and the OVA1 score work together to identify patients at higher risk of malignancy.
Impact of a Multivariate Index Assay on Referral Patterns for Surgical Management of an Adnexal Mass
This study explores how the use of a multivariate index assay influences referral patterns for surgical management of adnexal masses.
Clinical Performance of a Multivariate Index Assay for Detecting Early-Stage Ovarian Cancer
Analysis of test performance revealed that Ova1 plus clinical assessment maintained a sensitivity of 95.3% which was superior to clinical assessment alone 68.6%, CA125 62.8%, and modified ACOG guidelines 76.7%.
Ovarian Malignancy Risk Stratification of Adnexal Masses Using a Multifactor Blood Test
Research shows promising results in ovarian malignancy risk stratification of adnexal masses using a multifactor blood test, offering a non-invasive and effective approach to assessing ovarian cancer risk.
Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors
Objective of the study was to compare the effectiveness of physician assessment with a new multivariate index assay in identifying high-risk ovarian tumors.
Want to know the latest updates, news, and events?
Join our newsletter